Hydrogen sulphide: A novel physiological inhibitor of LDL atherogenic modification by HOCl

References

• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320(14)915–924
   PubMed Web of Science ®Google Scholar
• Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91(9)2488–2496
   PubMed Web of Science ®Google Scholar
• Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20(5)707–727
   PubMed Web of Science ®Google Scholar
• Steinberg D. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997; 95(4)1062–1071
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall. FASEB J 1999; 13(10)1113–1120
   PubMedGoogle Scholar
• McMillen TS, Heinecke JW, LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005; 111(21)2798–2804
   PubMed Web of Science ®Google Scholar
• Winterbourn CC, Vissers MC, Kettle AJ. Myeloperoxidase. Curr Opin Hematol 2000; 7(1)53–58
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase: Friend and foe. J Leukoc Biol 2005; 77(5)598–625
   PubMed Web of Science ®Google Scholar
• Malle E, Marsche G, Arnhold J, Davies MJ. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta 2006; 1761(4)392–415
   PubMed Web of Science ®Google Scholar
• Fabjan JS, Abuja PM, Schaur RJ, Sevanian A. Hypochlorite induces the formation of LDL( − ), a potentially atherogenic low density lipoprotein subspecies. FEBS Lett 2001; 499(1)69–72
   PubMedGoogle Scholar
• Malle E, Waeg G, Schreiber R, Grone EF, Sattler W, Grone HJ. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: Colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000; 267(14)4495–4503
   PubMedGoogle Scholar
• Malle E, Wag G, Thiery J, Sattler W, Grone HJ. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol. Biochem Biophys Res Commun 2001; 289(4)894–900
   PubMedGoogle Scholar
• Van Antwerpen P, Boudjeltia KZ, Babar S, Legssyer I, Moreau P, Moguilevsky N, Vanhaeverbeek M, Ducobu J, Neve J. Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation. Biochem Biophys Res Commun 2005; 337(1)82–88
   PubMedGoogle Scholar
• Carr AC, Tijerina T, Frei B. Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein. Biochem J 2000; 346: 491–499
   PubMed Web of Science ®Google Scholar
• Wang R. Two's company, three's a crowd: Can H2S be the third endogenous gaseous transmitter?. FASEB J 2002; 16(13)1792–1798
   PubMed Web of Science ®Google Scholar
• Richardson CJ, Magee EA, Cummings JH. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 2000; 293(1–2)115–125
   PubMedGoogle Scholar
• Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. EMBO J 2001; 20(21)6008–6016
   PubMed Web of Science ®Google Scholar
• Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19(9)1196–1198
   PubMedGoogle Scholar
• Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 2005; 19(6)623–625
   PubMedGoogle Scholar
• Bhatia M, Sidhapuriwala J, Moochhala SM, Moore PK. Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat. Br J Pharmacol 2005; 145(2)141–144
   PubMed Web of Science ®Google Scholar
• Mok YY, Atan MS, Yoke PC, Zhong JW, Bhatia M, Moochhala S, Moore PK. Role of hydrogen sulphide in haemorrhagic shock in the rat: Protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol 2004; 143(7)881–889
   PubMedGoogle Scholar
• Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 2005; 333(4)1146–1152
   PubMed Web of Science ®Google Scholar
• Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun 1997; 237(3)527–531
   PubMed Web of Science ®Google Scholar
• Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, Tang C. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19(2)75–80
   PubMedGoogle Scholar
• Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, Halliwell B, Moore PK. The novel neuromodulator hydrogen sulfide: An endogenous peroxynitrite ‘scavenger’?. J Neurochem 2004; 90(3)765–768
   PubMed Web of Science ®Google Scholar
• Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, Armstrong JS, Moore PK. Hydrogen sulphide: A novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?. Biochem Biophys Res Commun 2005; 326(4)794–798
   PubMedGoogle Scholar
• Beauchamp RO, Jr., Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol 1984; 13(1)25–97
   PubMed Web of Science ®Google Scholar
• Hermann M, Gmeiner B. Altered susceptibility to in vitro oxidation of LDL in LDL complexes and LDL aggregates. Arterioscler Thromb 1992; 12(12)1503–1506
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193(1)265–275
   PubMed Web of Science ®Google Scholar
• Kapiotis S, Jirovetz L, Hermann M, Laggner H, Exner M, Esterbauer H, Gmeiner BM. Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification. Biochimie 2006; 88(7)785–791
   PubMedGoogle Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989; 6(1)67–75
   PubMed Web of Science ®Google Scholar
• Yan LJ, Traber MG, Packer L. Spectrophotometric method for determination of carbonyls in oxidatively modified apolipoprotein B of human low-density lipoproteins. Anal Biochem 1995; 228(2)349–351
   PubMedGoogle Scholar
• Desser RK, Himmelhoch SR, Evans WH, Januska M, Mage M, Shelton E. Guinea pig heterophil and eosinophil peroxidase. Arch Biochem Biophys 1972; 148(2)452–465
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KL, Wolff SP. Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 1996; 313: 781–786
   PubMed Web of Science ®Google Scholar
• Dypbukt JM, Bishop C, Brooks WM, Thong B, Eriksson H, Kettle AJ. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic Biol Med 2005; 39(11)1468–1477
   PubMedGoogle Scholar
• Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318(3)756–763
   PubMed Web of Science ®Google Scholar
• Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest 1996; 97(6)1535–1544
   PubMed Web of Science ®Google Scholar
• Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286(17)2136–2142
   PubMed Web of Science ®Google Scholar
• Hawkins CL, Pattison DI, Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003; 25(3–4)259–274
   PubMed Web of Science ®Google Scholar
• Prutz WA. Hypochlorous acid interactions with thiols, nucleotides, DNA, and other biological substrates. Arch Biochem Biophys 1996; 332(1)110–120
   PubMed Web of Science ®Google Scholar
• Pattison DI, Davies MJ. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol 2001; 14(10)1453–1464
   PubMed Web of Science ®Google Scholar
• Jerlich A, Fritz G, Kharrazi H, Hammel M, Tschabuschnig S, Glatter O, Schaur RJ. Comparison of HOCl traps with myeloperoxidase inhibitors in prevention of low density lipoprotein oxidation. Biochim Biophys Acta 2000; 1481(1)109–118
   PubMedGoogle Scholar
• Babior BM. Phagocytes and oxidative stress. Am J Med 2000; 109(1)33–44
   PubMed Web of Science ®Google Scholar
• Krasowska A, Konat GW. Vulnerability of brain tissue to inflammatory oxidant, hypochlorous acid. Brain Res 2004; 997(2)176–184
   PubMedGoogle Scholar
• Claesson R, Granlund-Edstedt M, Persson S, Carlsson J. Activity of polymorphonuclear leukocytes in the presence of sulfide. Infect Immun 1989; 57(9)2776–2781
   PubMedGoogle Scholar
• Park CM, Nagel RL, Blumberg WE, Peisach J, Magliozzo RS. Sulfhemoglobin. Properties of partially sulfurated tetramers. J Biol Chem 1986; 261(19)8805–8810
   PubMedGoogle Scholar
• Mitsuhashi H, Yamashita S, Ikeuchi H, Kuroiwa T, Kaneko Y, Hiromura K, Ueki K, Nojima Y. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 2005; 24(6)529–534
   PubMedGoogle Scholar
• Jiang HL, Wu HC, Li ZL, Geng B, Tang CS. Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 2005; 25(8)951–954
   PubMedGoogle Scholar